Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Accretive Health, Inc.

Wed Feb 27, 2013 1:42pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

NEW YORK,  Feb. 27, 2013  /PRNewswire/ -- Attorney Advertising -- Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of Accretive Health, Inc. ("Accretive Health" or
the "Company") (NYSE: AH).  The investigation focuses on whether the Company and
its executives violated federal securities laws.  

On  February 27, 2013, shares of Accretive health fell 25% to  $9.06  in
intraday trading, and had fallen more than 26% at one point, in the wake of a
release issued late Tuesday that said it would postpone the Company's financial
results for the fourth quarter and full year 2012.  The Company said it is
evaluating the timing of revenue recognition for its revenue cycle management
pacts it has with its clients.  The Company added if a change is warranted, it
may have to restate prior financial statements.   

If you are aware of any facts relating to this investigation, or purchased
shares of Accretive Health, you can assist this investigation by contacting
either  Peretz Bronstein  or  Eitan Kimelman  of Bronstein, Gewirtz & Grossman,
LLC at 212-697-6484 or via email  Those who inquire by e-mail
are encouraged to include their mailing address and telephone number.  

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our
primary expertise is the aggressive pursuit of litigation claims on behalf of
our clients.  In addition to representing institutions and other investor
plaintiffs in class action security litigation, the firm's expertise includes
general corporate and commercial litigation, as well as securities arbitration. 
Attorney advertising. Prior results do not guarantee similar outcomes.

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein  or  Eitan Kimelman, 212-697-6484

SOURCE  Bronstein, Gewirtz & Grossman, LLC

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.